Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07493915Recruiting

Precision Rehabilitation for Veterans With (HFpEF)

Role: collaborator

NCT04999995Completed

Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure

Role: collaborator

NCT06953830Not ApplicableEnrolling By Invitation

Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease

Role: lead

NCT02210936Not ApplicableCompleted

SCOSI-M: Preventing Prescription Drug Problems

Role: collaborator

NCT03843671Phase 2Unknown

Hyperbaric Radiation Sensitization of Head and Neck Cancers

Role: collaborator

NCT00746759Completed

Airway Epithelium Gene Expression: AEGIS IDE

Role: collaborator

NCT01812512Phase 1Withdrawn

Telehealth Self Management for CHF

Role: collaborator

NCT00625105Not ApplicableUnknown

Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans

Role: lead

All 8 trials loaded